epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Maxitrol

neomycin/ polymyxin B/ dexamethasone ophthalmic

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  OINTMENT: 3.5 mg/10,000 units/1 mg per g; SUSPENSION: 3.5 mg/10,000 units/1 mg per mL

ocular inflammation

[ointment]
Dose: apply in eye(s) tid-qid; Info: for ocular inflammation with superficial bacterial infection or risk; taper dose gradually to D/C if long-term use
[suspension]
Dose: 1-2 drops in eye(s) q4-6h; Info: for ocular inflammation with superficial bacterial infection or risk; taper dose gradually to D/C if long-term use; for severe disease, may start 1-2 drops in eye(s) q1h x1-2 days, then taper dose gradually to D/C

Peds Dosing .

Dosage forms:  OINTMENT: 3.5 mg/10,000 units/1 mg per g; SUSPENSION: 3.5 mg/10,000 units/1 mg per mL

ocular inflammation

[ointment, 2 yo and older (off-label)]
Dose: apply in eye(s) tid-qid; Info: for ocular inflammation with superficial bacterial infection or risk; taper dose gradually to D/C if long-term use
[suspension, 2 yo and older]
Dose: 1-2 drops in eye(s) q4-6h; Info: for ocular inflammation with superficial bacterial infection or risk; taper dose gradually to D/C if long-term use; for severe disease, may start 1-2 drops in eye(s) q1h x1-2 days, then taper dose gradually to D/C

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@7f6296f9
  • hypersensitivity to drug or ingredient
  • hypersensitivity to aminoglycosides
  • ocular viral infection
  • ocular mycobacterial infection
  • ocular fungal infection
  • corneal abrasion
  • abrupt withdrawal (long-term use)
  • caution: hypersensitivity to corticosteroids
  • caution: glaucoma
  • caution: corneal thinning
  • caution: scleral thinning
  • caution: HSV infection history

Drug Interactions .

Overview

dexamethasone ophthalmic

corticosteroid ophthalmic

Interaction Characteristics:
  • delays ocular healing
  • immunomodulatory effects

neomycin ophthalmic

aminoglycoside ophthalmic

Interaction Characteristics:
    None

polymyxin B ophthalmic

polypeptide antibiotic

Interaction Characteristics:
    None

Avoid/Use Alternative

  • cladribine oral
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cladribine oral
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + cladribine oral

    use alternative: combo may incr. risk of serious infection (additive effects)

  • clobetasol ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    clobetasol ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + clobetasol ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • dexamethasone ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    dexamethasone ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + dexamethasone ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • difluprednate ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    difluprednate ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + difluprednate ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • fluocinolone intravitreal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fluocinolone intravitreal
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + fluocinolone intravitreal

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • fluorometholone ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fluorometholone ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + fluorometholone ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • hydrocortisone ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    hydrocortisone ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + hydrocortisone ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • loteprednol ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    loteprednol ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + loteprednol ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • natalizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    natalizumab
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + natalizumab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • pimecrolimus topical
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    pimecrolimus topical
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + pimecrolimus topical

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • prednisolone ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    prednisolone ophthalmic
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + prednisolone ophthalmic

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • triamcinolone intravitreal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    triamcinolone intravitreal
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + triamcinolone intravitreal

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

  • triamcinolone suprachoroidal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    triamcinolone suprachoroidal
    1 interaction

    Avoid/Use Alternative

    dexamethasone ophthalmic + triamcinolone suprachoroidal

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may slow or delay ocular wound healing (additive effects, duplicate therapy)

Monitor/Modify Tx

  • carfilzomib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    dexamethasone ophthalmic + carfilzomib

    consider antiviral prophylaxis: combo may incr. risk of serious infection (additive effects)

  • everolimus
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    dexamethasone ophthalmic + everolimus

    admin. PCP prophylaxis: combo may incr. risk of serious infection (additive effects)

  • mitomycin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    dexamethasone ophthalmic + mitomycin

    caution advised; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of serious infection (additive effects)

Caution Advised

  • abatacept
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    abatacept
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + abatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • abrocitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    abrocitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + abrocitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • acalabrutinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    acalabrutinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + acalabrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • adalimumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    adalimumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + adalimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • afamitresgene autoleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    afamitresgene autoleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + afamitresgene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • aldesleukin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    aldesleukin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + aldesleukin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • alemtuzumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    alemtuzumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + alemtuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anakinra
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    anakinra
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + anakinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anifrolumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    anifrolumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + anifrolumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anti-thymocyte globulin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    anti-thymocyte globulin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • atidarsagene autotemcel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    atidarsagene autotemcel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + atidarsagene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • avacopan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    avacopan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + avacopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • axicabtagene ciloleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    axicabtagene ciloleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + axicabtagene ciloleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azacitidine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    azacitidine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + azacitidine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azathioprine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    azathioprine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + azathioprine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • baricitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    baricitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + baricitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • basiliximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    basiliximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + basiliximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • beclomethasone inhaled
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    beclomethasone inhaled
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + beclomethasone inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • beclomethasone nasal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    beclomethasone nasal
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + beclomethasone nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • belatacept
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    belatacept
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + belatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belimumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    belimumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + belimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belinostat
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    belinostat
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + belinostat

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bendamustine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    bendamustine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + bendamustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • betamethasone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    betamethasone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + betamethasone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • bimekizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    bimekizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + bimekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • blinatumomab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    blinatumomab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + blinatumomab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bortezomib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    bortezomib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + bortezomib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • brentuximab vedotin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    brentuximab vedotin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + brentuximab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • brexucabtagene autoleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    brexucabtagene autoleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + brexucabtagene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • brodalumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    brodalumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + brodalumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bromfenac ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    bromfenac ophthalmic
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + bromfenac ophthalmic

    caution advised: combo may slow or delay ocular wound healing (additive effects)

  • budesonide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    budesonide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + budesonide

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide inhaled
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    budesonide inhaled
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + budesonide inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide nasal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    budesonide nasal
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + budesonide nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide rectal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    budesonide rectal
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + budesonide rectal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • busulfan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    busulfan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + busulfan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cabazitaxel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cabazitaxel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cabazitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • canakinumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    canakinumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + canakinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carboplatin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    carboplatin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + carboplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carmustine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    carmustine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + carmustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • certolizumab pegol
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    certolizumab pegol
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + certolizumab pegol

    caution advised: combo may incr. risk of serious infection (additive effects)

  • chlorambucil
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    chlorambucil
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + chlorambucil

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ciclesonide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ciclesonide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ciclesonide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ciltacabtagene autoleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ciltacabtagene autoleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ciltacabtagene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cisplatin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cisplatin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cisplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cladribine injection
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cladribine injection
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cladribine injection

    caution advised: combo may incr. risk of serious infection (additive effects)

  • clofarabine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    clofarabine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + clofarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • coccidioides immitis skin test antigen
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    coccidioides immitis skin test antigen
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + coccidioides immitis skin test antigen

    caution advised: combo may interfere with test results (antagonistic effects)

  • copanlisib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    copanlisib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + copanlisib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • corticotropin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    corticotropin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + corticotropin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cortisone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cortisone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cortisone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • crovalimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    crovalimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + crovalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cyclophosphamide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cyclophosphamide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cyclophosphamide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cyclosporine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cyclosporine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cyclosporine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cytarabine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    cytarabine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + cytarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dactinomycin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    dactinomycin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + dactinomycin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • danicopan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    danicopan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + danicopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • daratumumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    daratumumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + daratumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • daunorubicin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    daunorubicin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + daunorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • decitabine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    decitabine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + decitabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deflazacort
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    deflazacort
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + deflazacort

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • delgocitinib topical
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    delgocitinib topical
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + delgocitinib topical

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deucravacitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    deucravacitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + deucravacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deuruxolitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    deuruxolitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + deuruxolitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dexamethasone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    dexamethasone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + dexamethasone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • diclofenac ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    diclofenac ophthalmic
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + diclofenac ophthalmic

    caution advised: combo may slow or delay ocular wound healing (additive effects)

  • dimethyl fumarate
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    dimethyl fumarate
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + dimethyl fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dinutuximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    dinutuximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + dinutuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • diroximel fumarate
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    diroximel fumarate
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + diroximel fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • docetaxel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    docetaxel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + docetaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • doxorubicin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    doxorubicin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + doxorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dupilumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    dupilumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + dupilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • duvelisib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    duvelisib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + duvelisib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • eculizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    eculizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + eculizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • efgartigimod alfa
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    efgartigimod alfa
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + efgartigimod alfa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elivaldogene autotemcel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    elivaldogene autotemcel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + elivaldogene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elotuzumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    elotuzumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + elotuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elranatamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    elranatamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + elranatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • emapalumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    emapalumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + emapalumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • epcoritamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    epcoritamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + epcoritamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • epirubicin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    epirubicin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + epirubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • eribulin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    eribulin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + eribulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etanercept
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    etanercept
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + etanercept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etoposide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    etoposide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + etoposide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etrasimod
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    etrasimod
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + etrasimod

    caution advised during and x5wk after etrasimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • etuvetidigene autotemcel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    etuvetidigene autotemcel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + etuvetidigene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fingolimod
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fingolimod
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + fingolimod

    caution advised during and x2mo after fingolimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • floxuridine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    floxuridine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + floxuridine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fludarabine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fludarabine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + fludarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fludrocortisone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fludrocortisone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + fludrocortisone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • flunisolide nasal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    flunisolide nasal
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + flunisolide nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • flurbiprofen ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    flurbiprofen ophthalmic
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + flurbiprofen ophthalmic

    caution advised: combo may slow or delay ocular wound healing (additive effects)

  • fluticasone furoate
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fluticasone furoate
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + fluticasone furoate

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluticasone propionate
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fluticasone propionate
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + fluticasone propionate

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fruquintinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    fruquintinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + fruquintinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • gemtuzumab ozogamicin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    gemtuzumab ozogamicin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + gemtuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • glofitamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    glofitamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + glofitamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • golimumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    golimumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + golimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • guselkumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    guselkumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + guselkumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • hydrocortisone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    hydrocortisone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + hydrocortisone

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • hydroxyurea
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    hydroxyurea
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + hydroxyurea

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ibritumomab tiuxetan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ibritumomab tiuxetan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ibritumomab tiuxetan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ibrutinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ibrutinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ibrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • icotrokinra
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    icotrokinra
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + icotrokinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idarubicin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    idarubicin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + idarubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idecabtagene vicleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    idecabtagene vicleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + idecabtagene vicleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idelalisib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    idelalisib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + idelalisib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ifosfamide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ifosfamide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ifosfamide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inebilizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    inebilizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + inebilizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • infliximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    infliximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + infliximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inotuzumab ozogamicin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    inotuzumab ozogamicin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + inotuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • iptacopan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    iptacopan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + iptacopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • irinotecan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    irinotecan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + irinotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • isatuximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    isatuximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + isatuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ixabepilone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ixabepilone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ixabepilone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ixekizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ixekizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ixekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ketorolac ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ketorolac ophthalmic
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ketorolac ophthalmic

    caution advised: combo may slow or delay ocular wound healing (additive effects)

  • lebrikizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    lebrikizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + lebrikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • leflunomide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    leflunomide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + leflunomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lenalidomide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    lenalidomide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + lenalidomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • linvoseltamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + linvoseltamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lisocabtagene maraleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    lisocabtagene maraleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + lisocabtagene maraleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lomustine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    lomustine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + lomustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • loncastuximab tesirine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    loncastuximab tesirine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + loncastuximab tesirine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + lymphocyte immune globulin, anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • marnetegragene autotemcel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    marnetegragene autotemcel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + marnetegragene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • melphalan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    melphalan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + melphalan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mercaptopurine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mercaptopurine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mercaptopurine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • methotrexate
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    methotrexate
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + methotrexate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • methylprednisolone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    methylprednisolone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + methylprednisolone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mirikizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mirikizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mirikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mitoxantrone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mitoxantrone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mitoxantrone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mogamulizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mogamulizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mogamulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • momelotinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    momelotinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + momelotinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mometasone implant
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mometasone implant
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mometasone implant

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mometasone inhaled
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mometasone inhaled
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mometasone inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mometasone nasal
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mometasone nasal
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mometasone nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • monomethyl fumarate
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    monomethyl fumarate
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + monomethyl fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mosunetuzumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mosunetuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mycophenolate mofetil
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mycophenolate mofetil

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mycophenolic acid
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    mycophenolic acid
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + mycophenolic acid

    caution advised: combo may incr. risk of serious infection (additive effects)

  • narsoplimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    narsoplimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + narsoplimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nelarabine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    nelarabine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + nelarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nepafenac ophthalmic
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    nepafenac ophthalmic
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + nepafenac ophthalmic

    caution advised: combo may slow or delay ocular wound healing (additive effects)

  • nipocalimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    nipocalimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + nipocalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • obecabtagene autoleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    obecabtagene autoleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + obecabtagene autoleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • obinutuzumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    obinutuzumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + obinutuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ocrelizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ocrelizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ocrelizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ofatumumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ofatumumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ofatumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • oxaliplatin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    oxaliplatin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + oxaliplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ozanimod
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ozanimod
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ozanimod

    caution advised during and x3mo after ozanimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • paclitaxel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    paclitaxel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + paclitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pegcetacoplan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    pegcetacoplan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + pegcetacoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pentostatin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    pentostatin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + pentostatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pirtobrutinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    pirtobrutinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + pirtobrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • polatuzumab vedotin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    polatuzumab vedotin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + polatuzumab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pomalidomide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    pomalidomide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + pomalidomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ponatinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ponatinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ponatinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ponesimod
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ponesimod
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ponesimod

    caution advised during and x1-2wk after ponesimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • pozelimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    pozelimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + pozelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • prednisolone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    prednisolone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + prednisolone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • prednisone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    prednisone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + prednisone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • procarbazine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    procarbazine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + procarbazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ravulizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ravulizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ravulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • regorafenib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    regorafenib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + regorafenib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • relacorilant
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    relacorilant
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + relacorilant

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rilonacept
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    rilonacept
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + rilonacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rilzabrutinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    rilzabrutinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + rilzabrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • risankizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    risankizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + risankizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ritlecitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ritlecitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ritlecitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rituximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    rituximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + rituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • romidepsin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    romidepsin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + romidepsin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ropeginterferon alfa-2b
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ropeginterferon alfa-2b
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ropeginterferon alfa-2b

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rozanolixizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    rozanolixizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + rozanolixizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ruxolitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ruxolitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ruxolitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ruxolitinib topical
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ruxolitinib topical
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ruxolitinib topical

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sarilumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sarilumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sarilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • satralizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    satralizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + satralizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • secukinumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    secukinumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + secukinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • selinexor
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    selinexor
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + selinexor

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sibeprenlimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sibeprenlimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sibeprenlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • siltuximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    siltuximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + siltuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • siponimod
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    siponimod
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + siponimod

    caution advised during and x3-4wk after siponimod tx: combo may incr. risk of serious infection; infection risk may be prolonged (additive effects)

  • sirolimus
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sirolimus
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sirolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sirolimus albumin-bound
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sirolimus albumin-bound
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sirolimus albumin-bound

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sonrotoclax
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sonrotoclax
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sonrotoclax

    caution advised: combo may incr. risk of serious infection (additive effects)

  • spesolimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    spesolimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + spesolimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sulfasalazine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sulfasalazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sutimlimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    sutimlimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + sutimlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tacrolimus
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tacrolimus
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tacrolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tafasitamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tafasitamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tafasitamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • talquetamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    talquetamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + talquetamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tarlatamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tarlatamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tarlatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teclistamab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    teclistamab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + teclistamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • temozolomide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    temozolomide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + temozolomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • temsirolimus
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    temsirolimus
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + temsirolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teplizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    teplizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + teplizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teriflunomide
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    teriflunomide
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + teriflunomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • thioguanine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    thioguanine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + thioguanine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • thiotepa
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    thiotepa
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + thiotepa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tildrakizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tildrakizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tildrakizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tisagenlecleucel
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tisagenlecleucel
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tisagenlecleucel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tocilizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tocilizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tocilizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tofacitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tofacitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tofacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • topotecan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    topotecan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + topotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • trabectedin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    trabectedin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + trabectedin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tralokinumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tralokinumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tralokinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • triamcinolone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    triamcinolone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + triamcinolone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • tuberculin purified protein derivative
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    tuberculin purified protein derivative
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + tuberculin purified protein derivative

    caution advised during and x5-6wk after dexamethasone ophthalmic tx: combo may interfere with test results (antagonistic effects)

  • ublituximab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ublituximab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ublituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • upadacitinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    upadacitinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + upadacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ustekinumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    ustekinumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + ustekinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vamorolone
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    vamorolone
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + vamorolone

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • vedolizumab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    vedolizumab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + vedolizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • venetoclax
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    venetoclax
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + venetoclax

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vilobelimab
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    vilobelimab
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + vilobelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinblastine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    vinblastine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + vinblastine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vincristine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    vincristine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + vincristine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinorelbine
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    vinorelbine
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + vinorelbine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • voclosporin
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    voclosporin
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + voclosporin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • zanubrutinib
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    zanubrutinib
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + zanubrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • zilucoplan
  • Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic)
    +
    zilucoplan
    1 interaction

    Caution Advised

    dexamethasone ophthalmic + zilucoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@6d82980c
  • optic nerve damage
  • cataracts
  • IOP elevated
  • glaucoma
  • vision changes
  • delayed ocular wound healing
  • secondary ocular infection
  • masking of infection symptoms
  • hypersensitivity reaction
  • anaphylaxis
  • anaphylactoid reaction
  • Stevens-Johnson syndrome
  • ulcerative keratitis

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@3c157400
  • ocular burning
  • ocular stinging
  • ocular irritation
  • IOP elevated

Safety/Monitoring .

Monitoring Parameters
IOP if tx >10 days

Look/Sound-Alike Drug Names
Maxitrol confused with: metipranolol

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy; no human data available, though risk of fetal harm not expected based on expected limited systemic absorption

Lactation

Clinical Summary

may use while breastfeeding; no human data available, though risk of infant harm and adverse effects on milk production not expected based on limited systemic absorption in breastfeeding patients

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@1f23bf2e

Metabolism: for neomycin: none; CYP450: none; Info: minimal systemic absorption; for polymyxin B: unknown; CYP450: unknown; Info: minimal systemic absorption; for dexamethasone: local primarily, liver; CYP450: 3A4 substrate; Info: minimal systemic absorption

Excretion: for neomycin: unknown; Half-life: unknown; for polymyxin B: unknown; Half-life: unknown; for dexamethasone: urine primarily; Half-life: 4h (plasma), 36-54h (biological)

Subclass: Antibacterial/Corticosteroid Combos, Ophthalmic

Mechanism of Action
for neomycin: binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis; for polymyxin B: increases cell wall permeability (polypeptide); for dexamethasone: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Sandoz Pharmaceuticals Inc. (OINT form) and Harrow Health, Inc. (SUSP form)

com.epocrates.rxweb.beans.DrugOtherInfoBean@749d276d

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

ophthalmic suspension:

  • 1 mg/3.5 mg/10000 units/mL (1 eye dropper, 5 mL): $122.00

ophthalmic ointment:

  • 3.5 mg/g/10000 units/g/0.1% (1 tube of ointment, 3.5 g): $208.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information